home / stock / entx / entx news

ENTX News and Press, Entera Bio Ltd. From 03/04/24

Stock Information
Company Name: Entera Bio Ltd.
Stock Symbol: ENTX
Market: NASDAQ
Website: enterabio.com
Menu
ENTX ENTX Quote ENTX Short ENTX News ENTX Articles ENTX Message Board
Get ENTX Alerts

News, Short Squeeze, Breakout and More Instantly...
ENTX - Entera Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement

JERUSALEM, March 04, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, announced today that it received notice from The NASDAQ Stock Market LLC (NASDAQ) on March 1, 2024, infor...
ENTX - Entera Bio files to sell 16.5M ordinary shares for holders

2024-02-02 16:23:29 ET More on Entera Bio Seeking Alpha’s Quant Rating on Entera Bio Historical earnings data for Entera Bio Financial information for Entera Bio Read the full article on Seeking Alpha For further details see: Entera Bio fil...

ENTX - Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

JERUSALEM, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced that it will participate and be available for investor meetings at the ...

ENTX - Entera Bio receives extension from Nasdaq to regain compliance with minimum bid price rule

2024-01-03 08:13:02 ET More on Entera Bio Seeking Alpha’s Quant Rating on Entera Bio Historical earnings data for Entera Bio Financial information for Entera Bio For further details see: Entera Bio receives extension from Nasdaq to regain complianc...
ENTX - Entera Bio Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule

JERUSALEM, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced that, on December 27, 2023, it received an extension of 180 calendar da...

ENTX - Entera Bio Announces Closing of Private Placement - Extends Cash Runway into 2025

JERUSALEM, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced that, on December 22, 2023, it closed a private placement with certain ...

ENTX - Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera's Next Generation Oral Peptide Platform

JERUSALEM, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, reported today interim data from an ongoing Phase 1 study designed to assess and ...
ENTX - Entera Bio GAAP EPS of -$0.08

2023-11-14 08:46:29 ET More on Entera Bio Seeking Alpha’s Quant Rating on Entera Bio Historical earnings data for Entera Bio Financial information for Entera Bio For further details see: Entera Bio GAAP EPS of -$0.08

ENTX - Entera Bio Reports Q3 2023 Financial Results, Highlights Transformational Steps and Unveils Vision as Premier Oral Peptide Company with Five Potential Programs in Development

JERUSALEM, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”), a leader in the development of orally delivered peptides and small therapeutic proteins, today reported corporate updates and financial results for the third quart...

ENTX - Entera Bio Reports Key Milestone Relating to Oral PTH (1-34) Peptide (EB613) Phase 3 Program: ASBMR-SABRE Has Submitted to FDA the Full Qualification Plan to Approve BMD as a Surrogate Endpoint for Osteoporosis

JERUSALEM, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, reports today that the American Society for Bone and Mineral Research (ASBMR) has...
Previous 10 Next 10